JP2016508026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508026A5 JP2016508026A5 JP2015542310A JP2015542310A JP2016508026A5 JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5 JP 2015542310 A JP2015542310 A JP 2015542310A JP 2015542310 A JP2015542310 A JP 2015542310A JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5
- Authority
- JP
- Japan
- Prior art keywords
- pca
- category
- composite value
- biomarker
- snppc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1251310 | 2012-11-20 | ||
| SE1251310-7 | 2012-11-20 | ||
| SE1350602 | 2013-05-16 | ||
| SE1350602-7 | 2013-05-16 | ||
| PCT/EP2013/074270 WO2014079874A1 (en) | 2012-11-20 | 2013-11-20 | Prognostic method for individuals with prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016508026A JP2016508026A (ja) | 2016-03-17 |
| JP2016508026A5 true JP2016508026A5 (enExample) | 2017-01-05 |
Family
ID=49713059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542310A Pending JP2016508026A (ja) | 2012-11-20 | 2013-11-20 | 前立腺癌を有する個体の予後診断方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10428385B2 (enExample) |
| EP (1) | EP2922970B1 (enExample) |
| JP (1) | JP2016508026A (enExample) |
| AU (1) | AU2013349721B2 (enExample) |
| CA (1) | CA2891394C (enExample) |
| ES (1) | ES2694409T3 (enExample) |
| RU (1) | RU2669809C2 (enExample) |
| WO (1) | WO2014079874A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY193914A (en) | 2012-03-05 | 2022-11-01 | Oy Arctic Partners Ab | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| KR20150110477A (ko) | 2012-11-20 | 2015-10-02 | 파디아 에이비 | 공격적인 전립선 암의 존재 또는 부존재를 나타내는 방법 |
| AU2015230017B2 (en) * | 2014-03-11 | 2021-06-17 | A3P Biomedical Ab | Method for detecting a solid tumor cancer |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| DK3123381T3 (da) | 2014-03-28 | 2023-11-27 | Opko Diagnostics Llc | Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer |
| WO2016160545A1 (en) | 2015-03-27 | 2016-10-06 | Opko Diagnostics, Llc | Prostate antigen standards and uses thereof |
| CN107530412A (zh) * | 2015-04-29 | 2018-01-02 | 欧普科诊断有限责任公司 | 用于主动监控前列腺癌的组合物和方法 |
| JP6570929B2 (ja) * | 2015-09-08 | 2019-09-04 | 国立研究開発法人農業・食品産業技術総合研究機構 | 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法 |
| JP7138112B2 (ja) * | 2017-02-01 | 2022-09-15 | ファディア・アクチボラゲット | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
| KR20200112922A (ko) * | 2018-01-22 | 2020-10-05 | 파디아 에이비 | 분석 결과를 조화시키는 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| AU2008212117B2 (en) | 2007-02-07 | 2014-09-11 | Decode Genetics Ehf. | Genetic variants contributing to risk of prostate cancer |
| US9732389B2 (en) * | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
| US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
| JP2015524052A (ja) | 2012-05-16 | 2015-08-20 | ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ | 前立腺癌の存在または不存在の提示方法 |
| KR20150110477A (ko) | 2012-11-20 | 2015-10-02 | 파디아 에이비 | 공격적인 전립선 암의 존재 또는 부존재를 나타내는 방법 |
-
2013
- 2013-11-20 ES ES13799501.5T patent/ES2694409T3/es active Active
- 2013-11-20 US US14/443,974 patent/US10428385B2/en active Active
- 2013-11-20 WO PCT/EP2013/074270 patent/WO2014079874A1/en not_active Ceased
- 2013-11-20 AU AU2013349721A patent/AU2013349721B2/en active Active
- 2013-11-20 RU RU2015124008A patent/RU2669809C2/ru active
- 2013-11-20 JP JP2015542310A patent/JP2016508026A/ja active Pending
- 2013-11-20 CA CA2891394A patent/CA2891394C/en active Active
- 2013-11-20 EP EP13799501.5A patent/EP2922970B1/en active Active
-
2019
- 2019-09-19 US US16/575,940 patent/US20200010912A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503301A5 (enExample) | ||
| JP2016508026A5 (enExample) | ||
| Halvorsen et al. | Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab | |
| AU2021232712B2 (en) | Method for detecting a solid tumor cancer | |
| Takeuchi et al. | The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer | |
| Okamura et al. | Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma | |
| Aly et al. | Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study | |
| JP2019049559A (ja) | 侵攻性前立腺癌の存在または不存在を判定する方法 | |
| Ma et al. | Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma | |
| Zhao et al. | Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma | |
| Wang et al. | Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma | |
| JP2017508970A5 (enExample) | ||
| JP2015524052A (ja) | 前立腺癌の存在または不存在の提示方法 | |
| ES2694409T3 (es) | Método de pronóstico para individuos con cáncer de próstata | |
| Zhou et al. | Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection | |
| Irvine et al. | Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers | |
| CN107657149B (zh) | 用于预测肝癌患者预后的系统 | |
| CN121726086A (zh) | 多组学评估 | |
| Fu et al. | A novel and validated inflammation-based score (IBS) predicts survival in patients with hepatocellular carcinoma following curative surgical resection: a STROBE-compliant article | |
| JP2020505928A (ja) | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 | |
| JP2020505928A5 (enExample) | ||
| Do et al. | Detection of sFas, sCD137, and IL-27 cytokines as potential biomarkers for hepatocellular carcinoma diagnosis | |
| Zou et al. | Identification and validation of a ten-gene set variation score as a diagnostic and prognostic stratification tool in hepatocellular carcinoma | |
| US20250210192A1 (en) | Methods for disease detection | |
| Graff et al. | Metabolites from blood and formalin-fixed, paraffin-embedded tissue from participants with low-and high-grade prostate cancer: a pilot study |